IL1B and acute respiratory distress syndrome: Given the anti-inflammatory effects of Dex by downregulating proinflammatory cytokines such as TNF-α, IL-1β, and IL-6, and upregulating anti-inflammatory cytokines such as IL-10, it is possible that Dex increases the expression of ENaC by preventing excessive inflammatory responses in LPS-induced ALI.